• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN 12CC SALINE SYRINGE (10CC); SALINE, VASCULAR ACCESS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN 12CC SALINE SYRINGE (10CC); SALINE, VASCULAR ACCESS FLUSH Back to Search Results
Model Number 8881570121
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/04/2020
Event Type  malfunction  
Manufacturer Narrative
The incident sample has been requested but to date has not been received for evaluation.If the sample is received, or if additional information pertinent to the incident is obtained a follow-up report will be submitted.As part of our manufacturing process, all device history records are reviewed and approved by quality, prior to release of product.
 
Event Description
The customer reported that when they attach the prefill syringe to the iv tubing and insert the syringe on to flush, some air into the line was noticed due to negative pressure push back.There was no harm to the patient involved.
 
Manufacturer Narrative
H 3 evaluation summary the device history record (dhr) was reviewed and nothing out of the ordinary has occurred during the process.A review of the incoming inspection reports for the syringes used in this batch showed that they were in conformance and were released accordingly.The equipment used was in proper functioning condition during the manufacturing, filling and packaging of this lot.One unopened syringe was returned to the manufacturing site for evaluation.The syringe was opened, and the air was pushed outside the syringe before letting go of the plunger.The plunger then receded back into the barrel letting air inside, confirming the observed phenomenon.The investigation demonstrated that no related issue was recorded throughout all the manufacturing and control processes.The manufacturing records, including autoclave documents, were reviewed and no possible related event occurred during the overall process for this lot.A review specifically for plunger and syringe defects was also performed and in the manufacturing records, nothing out of the ordinary had occurred.Also, each lot is released based on a quality sampling.As per the final quality inspection report of this lot, all specification criteria were conforming and was released for distribution meeting all established quality assurance acceptance levels.The returned sample was sent to the supplier of the syringes.The examination showed a slight bulge on the syringe just above the 10 ml mark of the label.A bulge is a slight deformation of the barrel, a variation of the diameter on the barrel length.The negative push back of the plunger into the syringe upon opening is most likely due to the bulge in the syringe near the 10 ml mark.The bulge is found to be inherent to the sterilization process and therefore, it is not considered a defect.The root cause of the phenomenon reported in the complaint is due to the process.No corrective or preventive action will be initiated at this time.This complaint will be used for tracking and trending purposes.
 
Manufacturer Narrative
H 3: evaluation summary: the device history record (dhr) was reviewed indicating that the product was released accomplishing all quality standards.As part of our manufacturing process, all dhrs are reviewed and approved by quality, prior to release of product.The equipment used was in proper functioning condition during the manufacturing, filling, and packaging of this lot.One unopened syringe was returned for the evaluation.The syringe was opened, and the air was pushed outside the syringe before letting go of the plunger.The plunger then receded back into the barrel letting air inside.Therefore, the issue reported by the customer is observed.The investigation demonstrated that, no issues were recorded throughout the manufacturing and control processes.The manufacturing records, including autoclave documents, were reviewed and no possible related event occurred during the overall process for this lot.A review was performed specifically for the plunger and syringe issues in the manufacturing records and no issues were found.Also, each lot is released based on an acceptable quality limits (aql) sampling.As per the final quality inspection report of this lot, all specification criteria were conforming.The product was in conformance to the specifications and was released for distribution, meeting all the established quality assurance acceptance levels.The returned sample was sent to the supplier of the syringes for the analysis.The examination showed a slight bulge on the syringe just above the 10 ml mark of the label.A bulge is a slight deformation of the barrel, a variation of the diameter on the barrel length.The negative push back of the plunger into the syringe upon opening is most likely due to the bulge in the syringe near the 10 ml mark.The rubber tip is designed with a larger outside diameter than the syringe barrel internal diameter.This design is intentional and prevents any leakage during use while providing a good seal to maintain sterility of the finished product.This design causes the rubber tip to put pressure on the barrel walls.When the syringe goes through the autoclave process, heat is created which likely causes the syringe barrel wall to form over the rubber tip creating this bulge above the 10ml mark where the rubber tip resides.Depending on the actual dimensions of the rubber tip, barrel internal diameter and autoclave processing, the extent of bulge may vary.The bulge is found to be inherent to the sterilization process and therefore, it is not considered as an issue.The root cause of the reported incident is due to the supplier¿s process.A formal investigation is not deemed necessary at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
12CC SALINE SYRINGE (10CC)
Type of Device
SALINE, VASCULAR ACCESS FLUSH
Manufacturer (Section D)
COVIDIEN
15 hampshire street
mansfield MA 02048
MDR Report Key9687410
MDR Text Key179379903
Report Number1282497-2020-08911
Device Sequence Number1
Product Code NGT
UDI-Device Identifier10884521000261
UDI-Public10884521000261
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,user f
Type of Report Initial,Followup,Followup
Report Date 07/07/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Model Number8881570121
Device Catalogue Number8881570121
Device Lot Number19I1144
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 02/05/2020
Initial Date FDA Received02/10/2020
Supplement Dates Manufacturer Received02/05/2020
02/05/2020
Supplement Dates FDA Received06/01/2020
07/07/2020
Patient Sequence Number1
-
-